Abstract
Factors predisposing to the phenotypic features of familial combined hyperlipidemia have not been clearly defined. In the course of investigating familial coronary artery disease in Utah, we identified a three-generation family in which multiple members were affected with type IIa hyperlipoproteinemia (HLP IIa), type IIb hyperlipoproteinemia (HLP IIb), or type IV hyperlipoproteinemia (HLP IV). Because several family members had relatively severe low-density lipoprotein (LDL) cholesterol elevation, in order to dissect the possible contribution to the plasma lipoprotein abnormalities in this pedigree, we identified a novel point mutation in the low-density lipoprotein receptor (LDLR) gene, a G-to-A transition at nucleotide position 337 in exon 4. This change substituted lysine for glutamic acid at codon 92 (D92K) of the LDL receptor. By means of mutant allele-specific amplification we determined that the mutation co-segregated with elevated cholesterol and LDL cholesterol in the plasma of family members with HLP IIa and HLP IIb, but not with the elevated plasma triglycerides seen in HLP IIb and HLP IV patients. Thus, in families with apparent familial combined hyperlipidemia, a defective LDLR allele and other genetic or environmental factors that elevate plasma triglycerides may account for the multiple lipid phenotypes observed in this kindred.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: November 5, 1999 / Accepted: January 8, 2000
Rights and permissions
About this article
Cite this article
Wu, L., Hopkins, P., Xin, Y. et al. Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities. J Hum Genet 45, 154–158 (2000). https://doi.org/10.1007/s100380050202
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380050202
This article is cited by
-
Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East
Orphanet Journal of Rare Diseases (2012)
-
Familial hypercholesterolemia
Current Treatment Options in Cardiovascular Medicine (2002)